Verrica Pharmaceuticals

VRCA56

Penny Stock

$0.99arrow_drop_up1.01%$0.01

Penny Stock

VRCA56

$0.99

arrow_drop_up1.01%$0.01

Penny Stock

Performance History

Key Stats
Open	$0.98
Prev. Close	$0.99
EPS	-1.84
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$45.34M
PE Ratio	-

	LOW	HIGH
Day Range	0.92	1.06
52 Week Range	0.70	11.41

Ratios







EPS	-1.84

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Verrica Pharmaceuticals (VRCA)

Verrica Pharmaceuticals Inc (VRCA) is a pharmaceutical company focused on developing and commercializing innovative treatments for skin diseases. The company's stock price history shows that it has experienced fluctuations in its value over time. Investors can monitor the stock price to make informed investment decisions. Additionally, VRCA's stock quote provides real-time information on its current trading price.

Investors can stay updated on VRCA's latest developments through its stock news. News articles can provide insights into the company's achievements, partnerships, and product advancements. A thorough analysis of VRCA's stock can help investors understand its performance and potential future growth. By examining key financial metrics, market trends, and industry comparisons, investors can evaluate the company's financial health and make informed investment decisions.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Mr. Ted White
Headquarters: West Chester
Employees: 22
Exchange: NASDAQ

add Verrica Pharmaceuticals to watchlist

Keep an eye on Verrica Pharmaceuticals

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Verrica Pharmaceuticals 's (VRCA) price per share?

The current price per share for Verrica Pharmaceuticals (VRCA) is $0.99. The stock has seen a price change of $0.01 recently, indicating a 1.01% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Verrica Pharmaceuticals (VRCA)?

For Verrica Pharmaceuticals (VRCA), the 52-week high is $11.41, which is 1.05K% from the current price. The 52-week low is $0.7, the current price is 41.47% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Verrica Pharmaceuticals (VRCA) a growth stock?

Verrica Pharmaceuticals (VRCA) has shown an average price growth of -4.13% over the past three years. It has received a score of 10 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Verrica Pharmaceuticals as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Verrica Pharmaceuticals (VRCA) stock price performance year to date (YTD)?

As of the latest data, Verrica Pharmaceuticals (VRCA) has a year-to-date price change of -85.4%. Over the past month, the stock has experienced a price change of -34.14%. Over the last three months, the change has been -64.73%. Over the past six months, the figure is -88.09%. Looking at a longer horizon, the five-year price change stands at -93.86%.

help

Is Verrica Pharmaceuticals (VRCA) a profitable company?

Verrica Pharmaceuticals (VRCA) has a net income of -$67M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 85.44% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 1.16K% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $5.12M, although specific revenue growth data is currently not available. The gross profit is $4.38M. Operating income is noted at -$65.76M. Furthermore, the EBITDA is -$73.39M.

help

What is the market capitalization of Verrica Pharmaceuticals (VRCA)?

Verrica Pharmaceuticals (VRCA) has a market capitalization of $45.35M. The average daily trading volume is 1, indicating the stock's liquidity and investor engagement.

News

VERRICA PHARMACEUTICALS

Verrica Pharmaceuticals Announces Acceptance of Two Abstracts Featuring Positive Preliminary Topline Results of VP-315 for the Treatment of Basal Cell Carcinoma at the 2024 Fall Clinical Dermatology Conference

VERRICA PHARMACEUTICALS

Verrica Pharmaceuticals Reports Second Quarter 2024 Financial Results

HEALTH

LAW & LEGAL ISSUES

PRODUCT / SERVICES ANNOUNCEMENT

Jul 1, 2024

Verrica Pharmaceuticals Announces Litigation Settlement with Dormer Laboratories, Inc.

HEALTH

CLINICAL STUDY

May 15, 2024

Verrica Pharmaceuticals Announces Amendment to Company’s Collaboration and License Agreement with Torii Pharmaceutical Co. Ltd. to Fund Global Pivotal Phase 3 Clinical Trial to Study YCANTH® for the Treatment of Common Warts

Planet Fitness To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Tuesday

May 13, 2024

Verrica Pharmaceuticals Inc. (VRCA) Reports Q1 Loss, Tops Revenue Estimates